🎄 Thank You and Best Wishes for 2025! 🎄 As we close the chapter of another incredible year, we want to take a moment to thank everyone who has been part of our journey in 2024. To our clients, partners, and colleagues: your trust, collaboration, and support have been the foundation of our growth. Every handshake - virtual or in-person - is an opportunity to create something exceptional. Together, we’ve laid the groundwork for meaningful achievements, and we are optimistic that 2025 will be a year of reaching new heights. Let’s make the coming year our best yet! Wishing you all a Merry Christmas and a fantastic start to 2025! 🎇🎇🎇
Outbound Pharma
Business Consulting and Services
Lewes, Delaware 900 followers
Business Development and Strategic Growth Advisory for Life Science Companies
About us
Outbound Pharma is a global business development consulting firm specializing in the Life Sciences industry. Clients return to us time and again because we are a trusted partner, helping them make better decisions at critical moments, refining their value proposition, driving improved sales performance, and creating greater shareholder returns. With senior executives and consultants across five continents, Outbound Pharma specializes in Business Development and Strategic Growth services, ranging from vendor selection to high-quality lead generation.
- Website
-
www.outboundpharma.com
External link for Outbound Pharma
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- Lewes, Delaware
- Type
- Privately Held
- Founded
- 2017
- Specialties
- biopharmaceuticals, medical devices, email marketing, lead generation, appointment setting , marketing services, business development , and life sciences
Locations
-
Primary
16192 Coastal Hwy
Lewes, Delaware 19958, US
Employees at Outbound Pharma
-
Darrell Coleman
Business Development Manager with a Personalized Client Approach
-
Shelley H.
BioPharma QA Leader | GLP, GCP, GMP
-
Kuljit Bhatia, Ph.D.
Executive leadership, Pharmaceutical R&D, CDMO, Specialty pharma, CMC, Business Development, and Technical Operations.
-
Claudio Rota
Business Development | Strategic Advisory | Life Sciences
Updates
-
According to Customer.io's “State of Messaging 2024”, multi-channel campaigns deliver 3–9x better conversions than relying on a single channel. But, the #LifeScience and #Healthcare industry is different and requires an approach that goes beyond multichannel. That’s why, at Outbound Pharma, we go further—crafting #omnichannel campaigns that seamlessly connect every touchpoint to engage your prospects, build trust, and drive meaningful conversations that move opportunities forward. Because while email remains the cornerstone of any outreach campaign, there is lots more that goes into an effective outreach strategy as we move into 2025. To celebrate the end of the year, we have decided to unveil the #strategies that we use in our omnichannel mix. In the next few days, we will give away valuable tips and tactics that we use to succeed in the life science industry. So, follow us for these exciting news ahead! 🌟 #BusinessDevelopment #LeadGeneration
-
Outbound Pharma is excited to announce a strategic partnership with Zeeks - Art for Geeks, an exceptional team of scientific experts and creative communicators. They bring science to life through expert podcasts that turn complex ideas into captivating stories. Together, we will amplify our clients' messages and build deeper engagement, positioning their brands to stand out within their competitive market. With Outbound Pharma's business development and strategy expertise, we'll connect clients with the right decision-makers. It's a partnership that drives quicker outcomes, deeper connections, and richer impact to help our clients achieve their goals and deliver sustainable value. Learn more ▶️ https://lnkd.in/dK-SmBUD
-
We always say to our SaaS clients, "Lead generation takes time, effort, and a strategic approach." Feeling the pressure to generate leads and land clients - It’s a common challenge, but it's not impossible to overcome. Why is it so tough? ▪️ Competition: The SaaS market is booming and becoming increasingly crowded. ▪️ Long Sales Cycles: In B2B, especially in the life science industry, you often deal with complex solutions that require building trust and demonstrating value. This is a highly regulated industry and has much longer sales cycles. ▪️ Budget Constraints: Smaller companies typically have limited marketing budgets, making it challenging to compete with more established companies Where to Focus: Everything starts with your Value Proposition. You’re competing against established brands that have already carved out their space in the market. Nobody will know if your product or service is better until you show them why. ☑️ Be unique. ☑️ Distinguish yourself. ☑️ Claim the untaken seat—position yourself where no one else has. Once your value is clear and obvious, you can move on to strategies like: → Creating SEO-optimized content → Optimizing your website → Utilizing LinkedIn → Expanding your network etc. But none of these will work unless your foundation is solid. Your value must be undeniable. We’ve seen countless examples where companies overcame challenges by focusing on the right strategies and generating leads more effectively. Want actionable tips? Connect with us - We’re always happy to share insights and discuss your challenges. Free Consultation ➡️ https://lnkd.in/dYZYpykD
-
Outsourcing rates for CROs are expected to continue across most preclinical and clinical phases over the next 3 - 5 years. As the CRO market grows, so does the competition for suitable M&A targets. Identifying the right target requires more than just having access to company databases —it demands industry knowledge, strategic clarity, and resources. Key questions for your team: 1️⃣ Do you have a clear profile of your ideal M&A target? 2️⃣ Does your BD team have the bandwidth and expertise to scout in-depth? 3️⃣ Are you equipped to assess differentiators, scalability, and integration challenges effectively? Are you looking for possible acquisitions in the CRO space? Let’s discuss! #MergersAndAcquisitions #CRO #LifeSciences #BusinessDevelopment #StrategicGrowth #Toxicology #Preclinical
-
𝗢𝘂𝘁𝗯𝗼𝘂𝗻𝗱 𝗣𝗵𝗮𝗿𝗺𝗮'𝘀 𝟮𝟬𝟮𝟰 𝗬𝗲𝗮𝗿 𝗶𝗻 𝗥𝗲𝘃𝗶𝗲𝘄 This year has been nothing short of transformative for Outbound Pharma. As 2024 draws to a close, we’re proud to reflect on the significant impact we’ve made in enhancing the business development strategies of 21 diverse and innovative companies across the life sciences sector. A Snapshot of Our 2024 Clients: ☑️ 7 CROs (preclinical, clinical, and other services) ☑️ 5 SaaS Companies ☑️ 3 TechBio Companies ☑️ 2 Chemical/API Manufacturers ☑️ 1 Mid-size Pharmaceutical Company ☑️ 2 CDMOs ☑️ 1 Non-Profit Organization (Pharma-focused) ☑️ 2 Medical Device Manufacturers Our work centered on refining value propositions, optimizing sales strategies, and enhancing lead generation and outreach. These efforts empowered our clients to strengthen their commercial capabilities and close more impactful deals. 🌍 Geographically, our clients were distributed as follows: 35% in the United States 30% in the European Union 20% in India 15% in the Rest of the World 💡Reflecting on the Impact | Outbound Pharma’s strategic interventions in 2024 have delivered measurable results. We estimate that our efforts enabled these organizations to generate an additional $𝟱.𝟮 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗻𝗲𝗮𝗿-𝘁𝗲𝗿𝗺 𝗿𝗲𝘃𝗲𝗻𝘂𝗲, $𝟬.𝟱 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗰𝗼𝘀𝘁 𝘀𝗮𝘃𝗶𝗻𝗴𝘀 𝗶𝗻 𝘁𝗲𝗿𝗺𝘀 𝗼𝗳 𝘁𝗶𝗺𝗲 𝗮𝗻𝗱 𝗿𝗲𝘀𝗼𝘂𝗿𝗰𝗲𝘀, 𝗮𝗻𝗱 𝗮𝗻 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 $𝟲-𝟴 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗶𝗻𝗰𝗿𝗲𝗺𝗲𝗻𝘁𝗮𝗹 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗿𝗲𝘃𝗲𝗻𝘂𝗲 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝘁𝘄𝗼 𝘆𝗲𝗮𝗿𝘀. Looking Ahead to 2025 As we plan for the year ahead, we’re excited to continue empowering life sciences companies to surpass their sales goals and achieve sustained growth. Look forward to new service offerings, innovative strategies, and deeper collaborations. Let’s make 2025 even more impactful together—reach out to explore how we can accelerate your growth. Here’s to another successful year! Thank you for being part of our journey. 🤝
-
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐭𝐡𝐞 𝐕𝐚𝐥𝐮𝐞 𝐏𝐫𝐨𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐑𝐞𝐬𝐞𝐭 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩𝐬! Starting in January 2025, Outbound Pharma will offer a game-changing 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐬𝐞𝐫𝐯𝐢𝐜𝐞 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐫𝐬 who want to stand out in competitive markets and resonate with decision-makers in the Life Science industry. 𝐖𝐡𝐚𝐭 𝐘𝐨𝐮 𝐆𝐞𝐭: 6 hours of expert-led strategy live workshops, delivered over 2-4 weeks, that will transform how your company presents its value to the market. The format is online and they are designed to provide clear, actionable insights and tangible results for your business. 𝐓𝐡𝐞 𝐕𝐚𝐥𝐮𝐞 𝐘𝐨𝐮’𝐥𝐥 𝐆𝐚𝐢𝐧: ✅ Sharper Targeting Refine your Ideal Customer Profiles (ICP) to focus on high-value segments that deliver maximum ROI. ✅ A Compelling Value Proposition Walk away with messaging that speaks directly to your audience's pain points and sets you apart from competitors. ✅ Optimized Customer Segmentation Gain clear, actionable strategies for prioritizing your best prospects and aligning your resources for success. 𝐖𝐡𝐲 𝐓𝐡𝐢𝐬 𝐌𝐚𝐭𝐭𝐞𝐫𝐬: ☑️ These workshops are tailor-made for Life Science service providers —API manufacturers, CRO/CDMOs, chemical intermediates producers, and SaaS providers—looking to reset and refine their positioning for 2025. ☑️ You’ll gain clarity, confidence, and a competitive edge in your market. Let’s make 2025 the year your value proposition drives real results. Secure a 𝐅𝐑𝐄𝐄 𝐜𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐭𝐢𝐨𝐧! https://lnkd.in/dYZYpykD #ValuePropositionReset #LifeSciences #BusinessDevelopment #Biotech #CDMO
-
Do You Know What Your Biggest Outreach Challenges Are? 🤔 It’s easy to get caught up in the day-to-day, but what’s really challenging your organization from a sales outreach perspective? From our work with life sciences businesses, we see 5 major patterns which are consistent across multiple organizations and industry segments. What’s your biggest challenge right now? Drop your thoughts in the comments—I’d love to hear from you! 👇 #businessdevelopment #lifesciences #salesstrategy #growthmindset
-
🤔 Are we focusing on the wrong metrics in lead generation? For many companies, success is about one thing: high-quality meetings. But is that the best way to measure the success of a campaign? We analyzed 20 lead generation campaigns in the life sciences industry, and the results were eye-opening. The true value of lead generation goes far beyond short-term wins like meetings. What do you think? Are we putting too much weight on appointment setting as a metric? Let us know! 👇 Read the full article: https://lnkd.in/dxJu6uCR #leadgeneration #strategy #pharma
-
As if there weren’t already enough experts teaching you how to write the “best” email templates, here’s the one more from us: DO. YOUR. RESEARCH. Subject lines? Great Opening lines? Sure P.S.’s? Helpful Things not to say: Absolutely But if you skip your research, none of it will help you. ❌ Understand the 3 WHYs. Everything else is secondary. #emailmarketing #coldemail #leadgeneration #emailpersonalization #lifesciences #pharmamarketing @outboundpharma